Key result
Viral myocarditis is a multifactorial disease with presentations ranging from benign myopericarditis to heart failure, for which new diagnostic and therapeutic modalities are under investigation.
This review highlights the clinical spectrum, emerging pathogenesis, and potential future diagnostic and therapeutic modalities for viral myocarditis.
Answers are grounded in this paper and cite their sources.
Recognizes variable presentations in practice; leaves open validation of emerging diagnostics and therapies.
Although most cases of viral myocarditis are subclinical, some patients develop overt symptomatic disease. These patients may present with findings that range from benign myopericarditis to frank heart failure. Furthermore, a growing body of evidence links viral myocarditis with idiopathic dilated cardiomyopathy, sudden death, and chronic arrythmias. The pathogenesis of the disease is currently incompletely understood in humans but is being investigated in animal models. A multifactorial process involving direct viral damage, autoimmunity, and possibly vascular damage is emerging. Breakthroughs in rapid diagnosis, such as the use of DNA probes, are occurring and may soon provide the opportunity for early intervention. Although there is currently no widely accepted standard of treatment, promising new therapeutic modalities are under investigation. These include the use of general immunosuppressive agents, T cell monoclonal antibody, interferon, specific immunization, and synthetic antiviral agents.
No takes yet. Share an insight, caveat, or question.
See et al. (1991) conducted a review in Viral Myocarditis. Viral myocarditis is a multifactorial disease with presentations ranging from benign myopericarditis to heart failure, for which new diagnostic and therapeutic modalities are under investigation.
Synapse has enriched 10 related papers. Consider them for comparative context: